Forward together with innovation with the regions at the centre: Regions4PerMed

28th November – 10:00 – 12:45 – Session I & Session II
Education Track

Session I – 10:00 – 11:15 – Coordinating regional policies and innovation programmes in personalised medicine

There is an urgent need to start restructuring care delivery, fuelled by factors such as chronic diseases, Europe’s ageing population and health workforce shortages.   To tackle the challenges, new care models are needed and their implementation requires essential investments and related strategies. Involvement of a broad range of public and private partners and investors is required, with a combination of bottom-up and top-down approaches to realise necessary new care models.

When it comes to implementation of these, two underlying principles are collaboration and partnerships. When all concerned stakeholders – politicians, care authorities, care professionals, citizens/patients, service providers, technology providers and investors – are committed to working together, this should create a favourable environment for the design and deployment of new care models.   Regions4PerMed has the overarching goal of acting as a flagship for interregional cooperation in personalised medicine. From this, it will aim to align strategies and financial instruments, identify key investment areas, and release a European regional agenda in order to speed up the delivery of personalised health services to patients and citizens.

Regions4PerMed’s expected impact will be a strengthening of links between European regions setting up or planning personalised medicine healthcare approaches.   This will be achieved by ensuring regional representatives interact directly with each other, sharing activities, plans and strategies in respect of personalised medicine, exchanging views and concerns, finding fields of cooperation, and committing to concrete joint cooperation actions in the short-to-medium term.   Commitment is clearly crucial for any real and lasting impact and says it will maximise efforts and leverage on already established projects and initiatives.  As personalised medicine develops,     a number of good practices are emerging, not least regionally, which – individually and collectively – offer insights into how to design and implement successful new models.

Once again, this four-speaker session will encourage debate from the floor with as much interactive attendee involvement as possible.

Chair

Gianni D’Errico

Gianni D’Errico

Project Coordinator, Regions4permed

Panel

 Maurizio-Bersani

Maurizio Bersani

DG Welfare, Lombardy Region

Rafael Solana

Rafael Solana

General Secretary for Research, Development and Innovation, Regional Ministry of Health of Andalusia, Seville, Spain

Andrea Belardinelli

Andrea Belardinelli

Digital Health and Innovation – Tuscany Region

Richard Baker

Richard Barker

Founding Director, New Medicines Partners

Questions & Answers

Session II – 11:30 – 12:45 – Coordinating regional strategic investments

Europe’s achievements in science and technology have been significant and research and development efforts form an integral part of the European economy. The continent has been home to some of the most prominent researchers in various scientific disciplines, and the raw output of such research in Europe consistently ranks among the world’s best.  However, the EU and regions have struggled to bring innovation into the bloc’s healthcare systems.   The regions need to coordinate in a much smarter fashion to help address this issue, and this is at the heart of what Regions4PerMed is all about.  This session will touch on the policy initiatives directly involved over the years as well as looking toward the next legislative periods and the frameworks which could add support.

The format will see a chair plus six speakers, once again representing the political, institutional, regulator, patient, medical and scientific perspectives. Discussion from the floor, as well as questions and answers, are key to the session.

Chair

Richard Barker

Richard Barker

Founding Director, New Medicines Partners

Panel

 Fabio-Pammolli.

Fabio Pammolli

EFSI Investment Committee Member, EIB

Paola Pozzi

Paola Pozzi

Venture Consultant – Sofinnova Partners

Felicitas-RIEDL

Felicitas Riedl

Head of Life Sciences Division, EIB

Fabrizio Landi

Fabrizio Landi

President, Toscana Life Sciences

Anna-Sobczak

Anna Sobczak

European Commission, Policy Officer at Clusters, Social Economy & Entrepreneurship (DG GROW)

Questions & Answers